One biomanufacturing plant turns corn sugar into lysine, an amino acid mixed into pig and poultry feed, and the industry ships millions of tonnes of it a year.

Another takes a bag of white blood cells collected from one patient, engineers them to attack a cancer, and grows them into a single CAR-T dose for that same person.

What puts these two in the same trade?